跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRO-AMOXI CLAV - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRO-AMOXI CLAV
Authorized
STANDARD
PRO-AMOXI CLAV
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
68a1009c42a4c146
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
68a1009c42a4c146
Drug Approval Canada Name
PRO-AMOXI CLAV
Product Name
PRO-AMOXI CLAV
Status
Marketed
Status Date
2023-07-10
Original Market Date
2023-07-10
Din
02536501
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.16.08
Atc Original
J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 02
Aig Number
0234720005
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
CLAVULANIC ACID (CLAVULANATE POTASSIUM)
125 MG
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)
875 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
68a1009c42a4c146
Type
Standard
Back to Health Canada Approvals